Pe
Non verificato

PepGen Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute
04/03/2026
Mercato azionario
Eventi
Salute
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
1.00
04/03/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
PepGen Announces Regulatory Updates on FREEDOM2
1.00
03/03/2026
Eventi
Web e Social Network
Biotecnologia
Salute
PepGen to Participate in the Leerink Global Healthcare Conference
1.00
08/12/2025
Mercato del lavoro
Industria
Salute
Sanità
Farmaceutica
Biotecnologia
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
1.00
12/11/2025
Industria
Associazioni/Professionisti
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
1.00
12/11/2025
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
1.00
03/11/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
PepGen to Participate in Upcoming Investor Conferences
1.00
02/10/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Eventi
Industria
PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society
1.00
26/09/2025
Finanza
Biotecnologia
Farmaceutica
Sanità
Salute
Associazioni/Professionisti
Medicina - Varie
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0